[1]
“Preclinical Use of Group I Metabotropic Glutamate Receptors (Group I mGluRs) for Ischemic Stroke: Systematic Review and Meta-Analysis”, Am. J. Med. Sci. Innov., vol. 4, no. 2, pp. 118–126, Nov. 2025, doi: 10.54536/ajmsi.v4i2.6056.